Not for human or veterinary use 199 in stock Proudly crafted and produced in the USA
The chronic weight management segment is expected to grow at a CAGR of 13.45% during the forecast period, driven by expanding medical recognition of obesity as a chronic disease, increasing incorporation into dedicated weight-management programs, and growing demand for pharmacological alternatives to bariatric surgery
Stay hydrated, avoid overexertion, and monitor kidney health with regular check-ups if you have pre-existing kidney problems
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Keep taking it as prescribed by the doctor to get the maximum benefit